|
1
|
Makimoto Y, Nabeshima K, Iwasaki H,
Miyoshi T, Enatsu S, Shiraishi T, Iwasaki A, Shirakusa T and
Kikuchi M: Micropapillary pattern: A distinct pathological marker
to subclassify tumours with a significantly poor prognosis within
small peripheral lung adenocarcinoma (</=20 mm) with mixed
bronchioloalveolar and invasive subtypes (Noguchi's type C
tumours). Histopathology. 46:677–684. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miyoshi T, Satoh Y, Okumura S, Nakagawa K,
Shirakusa T, Tsuchiya E and Ishikawa Y: Early-stage lung
adenocarcinomas with a micropapillary pattern, a distinct
pathologic marker for a significantly poor prognosis. Am J Surg
Pathol. 27:101–109. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chao L, Yi-Sheng H, Yu C, Li-Xu Y, Xin-Lan
L, Dong-Lan L, Jie C, Yi-Lon W and Hui LY: Relevance of EGFR
mutation with micropapillary pattern according to the novel
IASLC/ATS/ERS lung adenocarcinoma classification and correlation
with prognosis in Chinese patients. Lung Cancer. 86:164–169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsumura M, Okudela K, Kojima Y, Umeda S,
Tateishi Y, Sekine A, Arai H, Woo T, Tajiri M and Ohashi K: A
histopathological feature of EGFR-mutated lung adenocarcinomas with
highly malignant potential-An implication of micropapillary
element. PLOS One. 11:e01667952016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Husain A, Farver C and Nicholson A:
Adenocarcinoma of the lung. WHO classification of tumours. Borczuk
A, Chan J, Cooper W, Dacic S, Kerr K, Lantuejoul S and Marx A: 5th
edition. IARC; Lyon: 2021
|
|
6
|
Fukutomi T, Hayashi Y, Emoto K, Kamiya K,
Kohno M and Sakamoto M: Low papillary structure in lepidic growth
component of lung adenocarcinoma: A unique histologic hallmark of
aggressive behavior. Hum Pathol. 44:1849–1858. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gracia Villacampa E, Larsson L, Mirzazadeh
R, Kvastad L, Andersson A, Mollbrink A, Kokaraki G, Monteil V,
Schultz N, Appelberg KS, et al: Genome-wide spatial expression
profiling in formalin-fixed tissues. Cell Genom. 1:1000652021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie L, Kong H, Yu J, Sun M, Lu S, Zhang Y,
Hu J, Du F, Lian Q, Xin H, et al: Spatial transcriptomics reveals
heterogeneity of histological subtypes between lepidic and acinar
lung adenocarcinoma. Clin Transl Med. 14:e15732024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takano Y, Suzuki J, Nomura K, Fujii G,
Zenkoh J, Kawai H, Kuze Y, Kashima Y, Nagasawa S, Nakamura Y, et
al: Spatially resolved gene expression profiling of tumor
microenvironment reveals key steps of lung adenocarcinoma
development. Nat Commun. 15:106372024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sobue T, Yamamoto S, Hara M, Sasazuki S,
Sasaki S and Tsugane S: Cigarette smoking and subsequent risk of
lung cancer by histologic type in middle-aged Japanese men and
women: the JPHC study. Int J Cancer. 99:245–251. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki M, Shinozaki-Ushiku A, Yuhara S,
Nagano M, Sato M and Ushiku T: The prognostic impact of
extra-alveolar invasion in lung adenocarcinoma. Lung Cancer.
205:1086122025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawai H, Miura T, Kawamatsu N, Nakagawa T,
Shiba-Ishii A, Yoshimoto T, Amano Y, Kihara A, Sakuma Y, Fujita K,
et al: Expression patterns of HNF4a, tTF-1, and SMARCA4 in lung
adenocarcinomas: Impacts on clinicopathological and genetic
features. Virchows Archiv. 486:343–354. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsumura M, Okudela K, Nakashima Y,
Mitsui H, Denda-Nagai K, Suzuki T, Arai H, Umeda S, Tateishi Y,
Koike C, et al: Specific expression of MUC21 in micropapillary
elements of lung adenocarcinomas-Implications for the progression
of EGFR-mutated lung adenocarcinomas. PLoS One. 14:e02152372019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu JI, Lin YP, Tseng CW, Chen HJ and Wang
LH: Crabp2 promotes metastasis of lung cancer cells via HuR and
integrin β1/FAK/ERK signaling. Sci Rep. 9:8452019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng X, Zhang M, Wang B, Zhou C, Mu Y, Li
J, Liu X, Wang Y, Song Z and Liu P: CRABP2 regulates invasion and
metastasis of breast cancer through hippo pathway dependent on ER
status. J Exp Clin Cancer Res. 38:3612019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu RZ, Li S, Garcia E, Glubrecht DD, Poon
HY, Easaw JC and Godbout R: Association between cytoplasmic CRABP2,
altered retinoic acid signaling, and poor prognosis in
glioblastoma. Glia. 64:963–976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu L, Su H, Zhao S, Si H, Xie H, Ren Y,
Gao J, Wang F, Xie X, Dai C, et al: Development of the semi-dry
dot-blot method for intraoperative detecting micropapillary
component in lung adenocarcinoma based on proteomics analysis. Br J
Cancer. 128:2116–2125. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai T, Adachi J, Dai Y, Nakano N, Yamato
M, Kikuchi S, Usui S, Minami Y, Tomonaga T, Noguchi M, et al:
In-depth proteomics reveals the characteristic developmental
profiles of early lung adenocarcinoma with epidermal growth factor
receptor mutation. Cancer Med. 12:10755–10767. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Han X, Zuo P, Zhang X and Xu H:
CEACAM5 stimulates the progression of non-small-cell lung cancer by
promoting cell proliferation and migration. J Int Med Res.
48:3000605209594782020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Li Y, Li J, Ma Y, Dai W, Mo S, Xu Y,
Li X and Cai S: FBW7 suppresses metastasis of colorectal cancer by
inhibiting HIF1α/CEACAM5 functional axis. Int J Biol Sci.
14:726–735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Süer H, Erus S, Cesur EE, Yavuz Ö,
Ağcaoğlu O, Bulutay P, Önder TT, Tanju S and Dilege Ş: Combination
of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph
node micrometastasis is a prognostic factor for non-small cell lung
cancer. J Cardiothorac Surg. 18:1892023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Odintsov I and Sholl LM: Prognostic and
predictive biomarkers in non-small cell lung carcinoma. Pathology.
56:192–204. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshimoto T, Matsubara D, Soda M, Ueno T,
Amano Y, Kihara A, Sakatani T, Nakano T, Shibano T, Endo S, et al:
Mucin 21 is a key molecule involved in the incohesive growth
pattern in lung adenocarcinoma. Cancer Sci. 110:3006–3011. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yi Y, Kamata-Sakurai M, Denda-Nagai K,
Itoh T, Okada K, Ishii-Schrade K, Iguchi A, Sugiura D and Irimura
T: Mucin 21/epiglycanin modulates cell adhesion. J Biol Chem.
285:21233–21240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Denda-Nagai K, Ishii-Schrade KB, Tian Y,
Okada K and Irimura T: Immunohistochemistry of mucin. Glycoscience
protocols (GlycoPODv2). Nishihara S, Angata K, Aoki-Kinoshita KF
and Hirabayashi J: Japan Consortium for Glycobiology and
Glycotechnology; Saitama: pp. p212021, PubMed/NCBI
|
|
26
|
Miyoshi T, Shirakusa T, Ishikawa Y,
Iwasaki A, Shiraishi T, Makimoto Y, Iwasaki H and Nabeshima K:
Possible mechanism of metastasis in lung adenocarcinomas with a
micropapillary pattern. Pathol Int. 55:419–424. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Djureinovic D, Pontén V, Landelius P, Al
Sayegh S, Kappert K, Kamali-Moghaddam M, Micke P and Ståhle E:
Multiplex plasma protein profiling identifies novel markers to
discriminate patients with adenocarcinoma of the lung. BMC Cancer.
19:7412019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lung Cancer Cohort Consortium (LC3), . The
blood proteome of imminent lung cancer diagnosis. Nat Commun.
14:30422023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim DJ, Kim WJ, Lim M, Hong Y, Lee SJ,
Hong SH, Heo J, Lee HY and Han SS: Plasma CRABP2 as a novel
biomarker in patients with non-small cell lung cancer. J Korean Med
Sci. 33:e1782018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lefebvre AM, Adam J, Nicolazzi C, Larois
C, Attenot F, Falda-Buscaiot F, Dib C, Masson N, Ternès N, Bauchet
AL, et al: The search for therapeutic targets in lung cancer:
Preclinical and human studies of carcinoembryonic antigen-related
cell adhesion molecule 5 expression and its associated molecular
landscape. Lung Cancer. 184:1073562023. View Article : Google Scholar : PubMed/NCBI
|
